Ahmed Jawad Kadhim, Hedef Dhafir El-Yaseen, Ali Mohammed Jawad
{"title":"Correlation of Klotho Protein with Troponin-I as a Marker of Myocardial Damage in Iraqi Beta-Thalassemia Major Patients.","authors":"Ahmed Jawad Kadhim, Hedef Dhafir El-Yaseen, Ali Mohammed Jawad","doi":"10.61186/rbmb.13.2.154","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Beta thalassemia is a hereditary blood condition characterized by a decrease or absence in the production of the beta-globin chain of hemoglobin. Patients with beta-thalassemia major often require regular blood transfusions and are at an increased risk of developing complications such as iron overload and cardiac injury. In recent years, there has been increasing interest in Klotho protein as a multifunctional protein known for its anti-aging and cardio-protective properties. Several studies have revealed a potential correlation between Troponin, a protein released into the circulation as a result of heart muscle damage, and the level of Klotho protein.</p><p><strong>Methods: </strong>This study included thirty Beta-Thalassemia Major (β-TM) patients and thirty control healthy subjects. Levels of Klotho protein and Troponin-I were determined using the ELISA technique and measured for all participants.</p><p><strong>Results: </strong>Serum Klotho protein and Troponin-I levels were significantly elevated in β-TM patients compared to healthy control subjects (P< 0.001). A positive correlation was found between serum Klotho protein and Troponin-I in the β-TM patients' group.</p><p><strong>Conclusions: </strong>A positive correlation was found between serum Klotho protein and Troponin-I in the β-TM patients, which may highlight a relationship between Klotho and cardiac damage.</p>","PeriodicalId":45319,"journal":{"name":"Reports of Biochemistry and Molecular Biology","volume":"13 2","pages":"154-158"},"PeriodicalIF":1.6000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11847582/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Biochemistry and Molecular Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.61186/rbmb.13.2.154","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Beta thalassemia is a hereditary blood condition characterized by a decrease or absence in the production of the beta-globin chain of hemoglobin. Patients with beta-thalassemia major often require regular blood transfusions and are at an increased risk of developing complications such as iron overload and cardiac injury. In recent years, there has been increasing interest in Klotho protein as a multifunctional protein known for its anti-aging and cardio-protective properties. Several studies have revealed a potential correlation between Troponin, a protein released into the circulation as a result of heart muscle damage, and the level of Klotho protein.
Methods: This study included thirty Beta-Thalassemia Major (β-TM) patients and thirty control healthy subjects. Levels of Klotho protein and Troponin-I were determined using the ELISA technique and measured for all participants.
Results: Serum Klotho protein and Troponin-I levels were significantly elevated in β-TM patients compared to healthy control subjects (P< 0.001). A positive correlation was found between serum Klotho protein and Troponin-I in the β-TM patients' group.
Conclusions: A positive correlation was found between serum Klotho protein and Troponin-I in the β-TM patients, which may highlight a relationship between Klotho and cardiac damage.
期刊介绍:
The Reports of Biochemistry & Molecular Biology (RBMB) is the official journal of the Varastegan Institute for Medical Sciences and is dedicated to furthering international exchange of medical and biomedical science experience and opinion and a platform for worldwide dissemination. The RBMB is a medical journal that gives special emphasis to biochemical research and molecular biology studies. The Journal invites original and review articles, short communications, reports on experiments and clinical cases, and case reports containing new insights into any aspect of biochemistry and molecular biology that are not published or being considered for publication elsewhere. Publications are accepted in the form of reports of original research, brief communications, case reports, structured reviews, editorials, commentaries, views and perspectives, letters to authors, book reviews, resources, news, and event agenda.